Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

574 ARTÍCULOS , VIENDO DEL 301 AL 315

Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease

Friedli MJ, Inestrosa NC.

Molecules. 2021 Oct 29;26(21):6531. doi: 10.3390/molecules26216531.

Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer's disease

Dhapola R, Hota SS, Sarma P, Bhattacharyya A, Medhi B, Reddy DH.

Inflammopharmacology. 2021 Dec;29(6):1669-1681. doi: 10.1007/s10787-021-00889-6. Epub 2021 Nov 23.

Advanced Nanoparticular Approaches to Combat Alzheimer's Disease

Shah R, Bhattacharya S.

Pharm Nanotechnol. 2021;9(5):308-316. doi: 10.2174/2211738509666211123091913.

Pharmacological Medical Treatment of Epilepsy in Patients with Dementia: A Systematic Review

Musaeus CS, Nilsson C, Cooper C, Kramberger MG, Verdelho A, Stefanova E, Religa D, Waldemar G, Frederiksen KS.

Curr Alzheimer Res. 2021;18(9):689-694. doi: 10.2174/1567205018666211126121529.

Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer's Disease

Jayatunga DPW, Hone E, Khaira H, Lunelli T, Singh H, Guillemin GJ, Fernando B, Garg ML, Verdile G, Martins RN.

Nutrients. 2021 Oct 23;13(11):3744. doi: 10.3390/nu13113744.

Impact of Donepezil and Memantine on Behavioral and Psychological Symptoms of Alzheimer Disease: Six-month Open-label Study

Bago Rožanković P, Rožanković M, Badžak J, Stojić M, Šušak Sporiš I.

Cogn Behav Neurol. 2021 Dec 2;34(4):288-294. doi: 10.1097/WNN.0000000000000285.

Cholinesterase inhibitors and memantine for the treatment of Alzheimer and non-Alzheimer dementias

Balázs N, Bereczki D, Kovács T.

Ideggyogy Sz. 2021 Nov 30;74(11-12):379-387. doi: 10.18071/isz.74.0379.

Gram-negative bacteria and their lipopolysaccharides in Alzheimer's disease: pathologic roles and therapeutic implications

Kim HS, Kim S, Shin SJ, Park YH, Nam Y, Kim CW, Lee KW, Kim SM, Jung ID, Yang HD, Park YM, Moon M.

Transl Neurodegener. 2021 Dec 7;10(1):49. doi: 10.1186/s40035-021-00273-y.

Multi-Target Directed Ligands (MTDLs): Promising Coumarin Hybrids for Alzheimer's Disease

Bhatia R, Chakrabarti SS, Kaur U, Parashar G, Banerjee A, Rawal RK.

Curr Alzheimer Res. 2021;18(10):802-830. doi: 10.2174/1567205018666211208140551.

Role of Receptors in Relation to Plaques and Tangles in Alzheimer's Disease Pathology

Sharma K, Pradhan S, Duffy LK, Yeasmin S, Bhattarai N, Schulte MK.

Int J Mol Sci. 2021 Nov 30;22(23):12987. doi: 10.3390/ijms222312987.

What have we learned from past failures of investigational drugs for Alzheimer's disease?

Imbimbo BP, Watling M.

Expert Opin Investig Drugs. 2021 Dec;30(12):1175-1182. doi: 10.1080/13543784.2021.2017881. Epub 2021 Dec 20.

The engagement of microglia in tau-targeted immunotherapy in Alzheimer's disease

Palova D, Turic Csokova N, Markova K, Kontsekova E, Kovacech B, Zilkova M.

Gen Physiol Biophys. 2021 Nov;40(6):463-478. doi: 10.4149/gpb_2021029.

Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia

Mühlbauer V, Möhler R, Dichter MN, Zuidema SU, Köpke S, Luijendijk HJ.

Cochrane Database Syst Rev. 2021 Dec 17;12(12):CD013304. doi: 10.1002/14651858.CD013304.pub2.

Small Molecule Drugs Targeting Non-Coding RNAs as Treatments for Alzheimer's Disease and Related Dementias

Nguyen LD, Chau RK, Krichevsky AM.

Genes (Basel). 2021 Dec 17;12(12):2005. doi: 10.3390/genes12122005.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias